ReviewIndian journal of ophthalmology2018
Community care for diabetic retinopathy and glaucoma in India: A panel discussion.
Review in Indian journal of ophthalmology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
8 citing papers in PubMed, 12 citations in OpenAlex.
- Training of nonophthalmologists in diabetic retinopathy screening.Indian journal of ophthalmology · 2021Article
- Recently updated global diabetic retinopathy screening guidelines: commonalities, differences, and future possibilities.Eye (London, England) · 2021Review
- Reaching the last mile in eye care.Indian journal of ophthalmology · 2020Article
- Universal health care: Can Indian ophthalmologist community set an example?Indian journal of ophthalmology · 2020Article
- Therapeutic effect of lutein supplement on non-proliferative diabetic retinopathy: A retrospective study.Medicine · 2019Article
- Management Of Glaucoma In Developing Countries: Challenges And Opportunities For Improvement.ClinicoEconomics and outcomes research : CEOR · 2019Review
- Paradigm shift - For effective management of diabetic retinopathy and glaucoma.Indian journal of ophthalmology · 2018Article
- Commentary on "Community care for diabetic retinopathy and glaucoma in India: A panel discussion".Indian journal of ophthalmology · 2018Article
Corrections and comments
- Commented on by
- Commented on by
Authors and funding
5 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Diabetic retinopathy (DR) and glaucoma are emerging causes of blindness and visual impairment in India and the world. Both diseases do not have any early warning symptoms, and once the symptoms appear, the diseases are reasonably advanced. Because of the long-standing nature of the diseases, one cannot adopt the cataract detection and treatment model so successfully developed in India. It requires an altogether different approach for screening and related infrastructure including human capital development. The solutions developed to reduce the burden of DR/glaucoma should be customized to urban, semi-urban, and rural areas. Greater advocacy, improving the health-seeking behavior, development of infrastructure and skilled personnel appropriate for the points of care, and an emphasis in comprehensive eye care are some of the solutions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.